These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16740837)

  • 1. Solicited adverse events after influenza immunization among infants, toddlers, and their household contacts.
    Skowronski DM; Jacobsen K; Daigneault J; Remple VP; Gagnon L; Daly P; Arsenault G; Landry M; Pielak K; Duval B; Tam T; De Serres G
    Pediatrics; 2006 Jun; 117(6):1963-71. PubMed ID: 16740837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential cost-effectiveness of annual influenza immunization for infants and toddlers: experience from Canada.
    Skowronski DM; Woolcott JC; Tweed SA; Brunham RC; Marra F
    Vaccine; 2006 May; 24(19):4222-32. PubMed ID: 16423432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and tolerability of cold-adapted influenza vaccine, trivalent, in infants younger than 6 months of age.
    Vesikari T; Karvonen A; Smith HM; Dunning A; Razmpour A; Saville MK; Gruber WC; Forrest BD
    Pediatrics; 2008 Mar; 121(3):e568-73. PubMed ID: 18299305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of inactivated trivalent influenza vaccine to parents of high-risk infants in the neonatal intensive care unit.
    Shah SI; Caprio M; Hendricks-Munoz K
    Pediatrics; 2007 Sep; 120(3):e617-21. PubMed ID: 17766502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of adverse reactions to whole-virion and split-virion influenza vaccines in hospital personnel.
    al-Mazrou A; Scheifele DW; Soong T; Bjornson G
    CMAJ; 1991 Aug; 145(3):213-8. PubMed ID: 2070311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trivalent inactivated influenza vaccine compliance rate in neonatal intensive care unit parents.
    Shah S; Caprio M
    Adv Neonatal Care; 2007 Dec; 7(6):295-8. PubMed ID: 18097211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine adverse events reported in post-marketing study of the Kitasato Institute from 1994 to 2004.
    Nakayama T; Onoda K
    Vaccine; 2007 Jan; 25(3):570-6. PubMed ID: 16945455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6-23 months of age.
    Rosenberg M; Sparks R; McMahon A; Iskander J; Campbell JD; Edwards KM
    Vaccine; 2009 Jul; 27(32):4278-83. PubMed ID: 19450636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring.
    Vellozzi C; Burwen DR; Dobardzic A; Ball R; Walton K; Haber P
    Vaccine; 2009 Mar; 27(15):2114-20. PubMed ID: 19356614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivated influenza vaccine (IIV) in children <2 years of age: examination of selected adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) after thimerosal-free or thimerosal-containing vaccine.
    McMahon AW; Iskander JK; Haber P; Braun MM; Ball R
    Vaccine; 2008 Jan; 26(3):427-9. PubMed ID: 18093701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trivalent inactivated influenza vaccine safety in children: assessing the contribution of telephone encounters.
    Mullooly JP; Crane B; Chun C
    Vaccine; 2006 Mar; 24(13):2256-63. PubMed ID: 16375995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does antigen-specific cytokine response correlate with the experience of oculorespiratory syndrome after influenza vaccine?
    Skowronski DM; Lu H; Warrington R; Hegele RG; De Serres G; HayGlass K; Stark D; White R; Macnabb J; Li Y; Manson HE; Brunham RC
    J Infect Dis; 2003 Feb; 187(3):495-9. PubMed ID: 12552434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid online identification of adverse events after influenza immunization in children by PCIRN's National Ambulatory Network.
    Bettinger JA; Vanderkooi OG; MacDonald J; Kellner JD
    Pediatr Infect Dis J; 2014 Oct; 33(10):1060-4. PubMed ID: 25361187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trivalent inactivated subunit influenza vaccine Influvac: 25-Year experience of safety and immunogenicity.
    Giezeman KM; Nauta J; de Bruijn IA; Palache AM
    Vaccine; 2009 Apr; 27(18):2414-7. PubMed ID: 19368782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oculo-respiratory syndrome: a new influenza vaccine-associated adverse event?
    Skowronski DM; Strauss B; De Serres G; MacDonald D; Marion SA; Naus M; Patrick DM; Kendall P
    Clin Infect Dis; 2003 Mar; 36(6):705-13. PubMed ID: 12627354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and tolerability of inactivated flu vaccine in high risk and healthy children.
    Avila Aguero ML; Soriano-Fallas A; Umaña-Sauma MA; Ulloa-Gutierrez R; Arnoux S
    Medicina (B Aires); 2007; 67(4):351-9. PubMed ID: 17891930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza vaccination in adults with asthma: safety of an inactivated trivalent influenza vaccine.
    Kmiecik T; Arnoux S; Kobryn A; Gorski P
    J Asthma; 2007 Dec; 44(10):817-22. PubMed ID: 18097856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial.
    Guerra FA; Blatter MM; Greenberg DP; Pichichero M; Noriega FR;
    Pediatrics; 2009 Jan; 123(1):301-12. PubMed ID: 19117896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse reactions to immunization with newer vaccines in the very preterm infant.
    Ellison VJ; Davis PG; Doyle LW
    J Paediatr Child Health; 2005 Aug; 41(8):441-3. PubMed ID: 16101980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.